2,2-Bis-methylol-3-chinuclidinol | 5291-31-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 奎宁环
• 英文名称: 2,2-Bis-methylol-3-chinuclidinol
• 英文别名: 2,2-bis-hydroxymethyl-1-aza-bicyclo[2.2.2]octan-3-ol；2,2-Bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-ol
• CAS: 5291-31-6
• 化学式: C₉H₁₇NO₃
• 分子量: 187.239
• InChiKey: DUCZTSWDCHMOFG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.8
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  63.9
• 氢给体数：
  3
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2,2-二羟基甲基-1-氮杂双环[2.2.2]辛-3-酮 在 lithium aluminium tetrahydride 作用下， 以60%的产率得到2,2-Bis-methylol-3-chinuclidinol
  参考文献：
  名称：

  Structure–activity studies of quinuclidinone analogs as anti-proliferative agents in lung cancer cell lines

  摘要：

  We have synthesized and tested novel quinuelidinone analogs to assay the effects on H1299 lung cancer cell lines alone or with gamma-radiation. We have found two series of quinuclidinone analogs that act as anti-cancer agents. Of these, four interesting analogs significantly decreased cell viability in H1299 lung cancer cell lines. Two derivatives decreased cell proliferation in a dose-dependent fashion alone or in the presence of gamma-radiation. Radiosensitization increased when derivative treatment preceded radiation treatment for both derivatives. These preliminary studies show an evidence for both additive and synergistic cytotoxicity for treatment of lung cancer by these novel quinuclidinone analogs. (C) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.11.085

文献信息

• WO2007/62030
  申请人：——

  公开号：——

  公开（公告）日：——
• Structure–activity studies of quinuclidinone analogs as anti-proliferative agents in lung cancer cell lines
  作者：Ahmed Malki、Aravinda B. Pulipaka、Susan C. Evans、Stephen C. Bergmeier

  DOI：10.1016/j.bmcl.2005.11.085

  日期：2006.3

  We have synthesized and tested novel quinuelidinone analogs to assay the effects on H1299 lung cancer cell lines alone or with gamma-radiation. We have found two series of quinuclidinone analogs that act as anti-cancer agents. Of these, four interesting analogs significantly decreased cell viability in H1299 lung cancer cell lines. Two derivatives decreased cell proliferation in a dose-dependent fashion alone or in the presence of gamma-radiation. Radiosensitization increased when derivative treatment preceded radiation treatment for both derivatives. These preliminary studies show an evidence for both additive and synergistic cytotoxicity for treatment of lung cancer by these novel quinuclidinone analogs. (C) 2005 Elsevier Ltd. All rights reserved.